ANRO - Wutah dodolan YoY (TTM) Alto Neuroscience, Inc.

Logo grafis altoneuroscience.com (ANRO)

Alto Neuroscience, Inc. (ANRO) generates revenue based on the implementation of AI-driven personalized psychiatry. The TTM annual revenue growth rate visualizes market expectations, with the current value standing at 0.00. However, the absence of current sales leaves the company dependent on external financing. Meanwhile, colossal demand for neurological drugs creates a foundation for a large-scale expansion of the client base in the future.

ANRO (altoneuroscience.com) riwayat Wutah pendapatan YoY sajrone 12 wulan kepungkur saka 23.11.2025 nganti 18.11.2026

Alto Neuroscience - rincian analitis lan metrik utama (ANRO)

- nilai pasar lan prakiraan target analis:
Analisis kabeh metrik perusahaan:Alto Neuro - ANRO
Produk asil prodhuksi altoneuroscience.com

The defensive portfolio is based on identifying assets with sustainable scaling dynamics. This metric calculates the percentage shift in revenue over a rolling year, neutralizing short-term reporting fluctuations. For Alto Neuroscience, Inc. (ANRO), operating in the high-uncertainty zone of the CNS, this serves as a critical filter for real progress. The indicator separates random inflows from systemic business growth. By analyzing the trend of sales changes year-over-year over a 12-month period, the investor assesses the viability of the biopharmaceutical model.